Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Marignani

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Annals of Hepatology|January 5, 2017
Sarcopenia predicts reduced survival in patients with hepatocellular carcinoma at first diagnosisPaola Begini, Elia Gigante, Giulio Antonelli, et al.
World Journal of Gastrointestinal Oncology|April 3, 2012
HCV infection, B-cell non-Hodgkin's lymphoma and immunochemotherapy: Evidence and open questionsMaria Christina Cox, Maria Antonietta Aloe-Spiriti, Elena Cavalieri, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 9, 2020
Hepatitis B vaccine coverage and risk factors for lack of vaccination in subjects with HBsAg negative liver cirrhosis in Italy: still, much work should be doneTommaso Stroffolini, Anna Lombardi, Alessia Ciancio, et al.
Journal of Medical Virology|December 28, 2020
Low influenza vaccination coverage in subjects with liver cirrhosis. An alert waiting for winter season 2020-2021 during the COVID-19 pandemicTommaso Stroffolini, Anna Lombardi, Alessia Ciancio, et al.
Scandinavian Journal of Infectious Diseases|August 20, 2014
Acute fulminant hepatitis E virus genotype 3e infection: description of the first case in EuropeStefano Festa, Anna Rosa Garbuglia, Flavia Baccini, et al.
Viruses|September 28, 2024
Prediction of Clinical Trajectory in HCV-Related ACLD after SVR: Role of Liver Stiffness in a 5-Years Prospective StudyFilomena Morisco, Alessandro Federico, Massimo Marignani, et al.
Tumori|October 12, 2012
Anti-Helicobacter pylori therapy in primary MALT lymphoma of rectumVitaliana De Sanctis, Massimo Marignani, Stefano Angeletti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 18, 2022
COVID-19 vaccination among cirrhotics in Italy: High coverage and effectiveness of 3 doses versus 2 in preventing breakthrough infection and hospitalizationTommaso Stroffolini, Alessia Ciancio, Alessandro Federico, et al.
Annals of Hematology|September 23, 2008
Is management with lamivudine always the appropriate choice for HBV patients with onco-hematologic diseases?M Christina Cox, Massimo Marignani, Barbara Veggia, et al.
Cancers|August 7, 2021
Risk Factors for Liver Decompensation and HCC in HCV-Cirrhotic Patients after DAAs: A Multicenter Prospective StudyFilomena Morisco, Alessandro Federico, Massimo Marignani, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Annals of Hepatology|January 5, 2017
Sarcopenia predicts reduced survival in patients with hepatocellular carcinoma at first diagnosisPaola Begini, Elia Gigante, Giulio Antonelli, et al.
World Journal of Gastrointestinal Oncology|April 3, 2012
HCV infection, B-cell non-Hodgkin's lymphoma and immunochemotherapy: Evidence and open questionsMaria Christina Cox, Maria Antonietta Aloe-Spiriti, Elena Cavalieri, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 9, 2020
Hepatitis B vaccine coverage and risk factors for lack of vaccination in subjects with HBsAg negative liver cirrhosis in Italy: still, much work should be doneTommaso Stroffolini, Anna Lombardi, Alessia Ciancio, et al.
Journal of Medical Virology|December 28, 2020
Low influenza vaccination coverage in subjects with liver cirrhosis. An alert waiting for winter season 2020-2021 during the COVID-19 pandemicTommaso Stroffolini, Anna Lombardi, Alessia Ciancio, et al.
Scandinavian Journal of Infectious Diseases|August 20, 2014
Acute fulminant hepatitis E virus genotype 3e infection: description of the first case in EuropeStefano Festa, Anna Rosa Garbuglia, Flavia Baccini, et al.
Viruses|September 28, 2024
Prediction of Clinical Trajectory in HCV-Related ACLD after SVR: Role of Liver Stiffness in a 5-Years Prospective StudyFilomena Morisco, Alessandro Federico, Massimo Marignani, et al.
Tumori|October 12, 2012
Anti-Helicobacter pylori therapy in primary MALT lymphoma of rectumVitaliana De Sanctis, Massimo Marignani, Stefano Angeletti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 18, 2022
COVID-19 vaccination among cirrhotics in Italy: High coverage and effectiveness of 3 doses versus 2 in preventing breakthrough infection and hospitalizationTommaso Stroffolini, Alessia Ciancio, Alessandro Federico, et al.
Annals of Hematology|September 23, 2008
Is management with lamivudine always the appropriate choice for HBV patients with onco-hematologic diseases?M Christina Cox, Massimo Marignani, Barbara Veggia, et al.
Cancers|August 7, 2021
Risk Factors for Liver Decompensation and HCC in HCV-Cirrhotic Patients after DAAs: A Multicenter Prospective StudyFilomena Morisco, Alessandro Federico, Massimo Marignani, et al.
Pageof 8